Clinical Data

Studies and Data

2025, Urology, Faurie et al

Outpatient PAHG injections under local anesthesia: prospective single‑center series. 

2025, Journal of Urogynecology, Lamblin et al.

Effectiveness and safety of urethral bulking with Bulkamid®: French multicenter cohort.  

2025, New England Journal of Medicine, Itkonen et al.

TS. TVT vs PAHG — 5‑year follow‑up.  

2024, The World Journal of Urology, Uleri et al.

One‑year outcomes of PAHG injection in women with stress and mixed UI.  

2023, Journal of Urological Surgery, Köseoğlu et al.

Minimally invasive treatment of female SUI with PAHG: Turkish cohort including mixed UI and prior failed surgery. 

2022, Journal of Urology, Itkonen et al.

TVT vs PAHG — 3‑year follow‑up from RCT.  

2022, BJU International, Hoe et al.

Long‑term outcomes of polyacrylamide hydrogel treatment in women with SUI. 

2021, Neurourology and Urodynamics, Brosche et al.

Seven‑year efficacy and safety outcomes of Bulkamid for SUI.  

2020, Journal of Urology, Itkonen et. Al

TVT vs PAHG for primary SUI — RCT.  

2020, The International Urogynecology Journal, Dwyer et al.

“Voice your choice”: Women’s choice of surgery for primary SUI.  

2019, Journal of Urology, Itkonen et al.

TS. TVT vs PAHG for primary SUI: randomized clinical trial. 

2015, Central European Journal of Urology, Pai et al.

Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid®) in stress and mixed urinary incontinence: 3‑year follow‑up.  

2014, Journal of Urology, Sokol et al.

Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: randomized, prospective, multicenter North American study. 

2013, The Archives of Gynecology Obstetrics, Leone et al.

Outpatient periurethral injections of polyacrylamide hydrogel for female stress urinary incontinence: effectiveness and safety.  

2012, The Journal of Sexual Medicine, Leone et al.

Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: impact on female sexual function. 

2012, International Urogynecology Journal, Toozs-Hobson et al.

Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress‑predominant mixed incontinence. 

2010, International Urogynecology Journal, Lose et al.

An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence.